Susceptibility of Gram-positive bacteria from ICU patients in UK hospitals to antimicrobial agents

Journal of Hospital Infection

Volumn 54, Issue 3, 2003, Pages 179-187

  Johnson, A P ^a   Henwood, C ^a   Mushtaq, S ^a   James, D ^a   Warner, M ^a   Livermore, D M ^a   Walker, A M ^b   Dunkin, K T ^b   Jacobson, S K ^c   Watts, J ^c   Smyth, E T M ^d   Hogg, G M ^d   McMaster, P ^d   Paul, J ^e   Spencer, R C ^f   Howe, R ^f   Wilson, G ^f   MacGowan, A P ^g   Bowker, K ^g   Brown, D F J ^h   Walpole, E ^h   Hosein, I K ⁱ   Paull, A ⁱ   Mannion, P T ^j   Fraser, S B ^j   Struthers, J K ^k   Thangkhiew, I ^k   Ackland, G ^k   Smyth, E ^l   Gemmell, C ^m   Clarke, J ^m   Wilcox, M ⁿ   Brayson, J ⁿ   Oppenheim, B ^o   Weston, D ^o   Sefton, A ^p   Hibbson, J ^p   Simpson, E ^p   Tebbutt, G M ^q   Bint, A ^r   Marshal, C ^r   Dance, D A B ^s   Matthews, R ^s   Chadwick, P R ^t   Cassey, S ^t   Elliott, J ^t   Warren, R E ^u   Howells, K ^u   Lowes, J A ^v   Tuck, A ^v   Dryden, M ^w   Speirs, A ^w   Anderson, A W ^x   Smith, L ^x   more..

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^b Bangor Hospital   (United Kingdom)

^c ROYAL UNITED HOSPITAL   (United Kingdom)

^d ROYAL VICTORIA HOSPITAL   (United Kingdom)

^e ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^f BRISTOL ROYAL INFIRMARY   (United Kingdom)

^g SOUTHMEAD HOSPITAL   (United Kingdom)

^h ADDENBROOKE S HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^j Countess of Chester Hospital ^*  (United Kingdom)

^k Hospital of Coventry and Warwickshire   (United Kingdom)

^l BEAUMONT HOSPITAL   (Ireland)

^m GLASGOW ROYAL INFIRMARY   (United Kingdom)

ⁿ LEEDS GENERAL INFIRMARY   (United Kingdom)

^o WITHINGTON HOSPITAL   (United Kingdom)

^p ROYAL LONDON HOSPITAL   (United Kingdom)

^q JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^r ROYAL VICTORIA INFIRMARY   (United Kingdom)

^s DERRIFORD HOSPITAL   (United Kingdom)

^t HOPE HOSPITAL   (United Kingdom)

^u ROYAL SHREWSBURY HOSPITAL   (United Kingdom)

^v SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^w ROYAL HAMPSHIRE COUNTY HOSPITAL   (United Kingdom)

^x YORK HOSPITAL   (United Kingdom)

more..

Author keywords

Antibiotic susceptibility; Gram positive bacteria; Intensive care units

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; METICILLIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN; COAGULASE;

ACTINOMYCETALES; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS; BACTERIUM DETECTION; BACTERIUM ISOLATE; COAGULASE POSITIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ENTEROCOCCUS; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; GRAM POSITIVE BACTERIUM; INTENSIVE CARE UNIT; MINIMUM INHIBITORY CONCENTRATION; NOCARDIA; NONHUMAN; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM; CLINICAL TRIAL; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MULTICENTER STUDY; PHYSIOLOGY; STAPHYLOCOCCUS;

COAGULASE; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; GRAM-POSITIVE BACTERIA; GREAT BRITAIN; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS;

EID: 0141888939     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(03)00145-2     Document Type: Article

References (22)

1. Donowitz L.G. Wenzel R.P. Hoyt J.W. High risk of hospital acquired infection in the ICU patient Crit Care Med 10 1982 355-357
2. Wenzel R.P. Thompson R.L. Landry S.M. Hospital acquired infections in intensive care unit patients: an overview with emphasis on epidemics Infect Control 4 1983 371-375
3. Vincent J.-L. Bihari D.J. Suter P.M. et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study JAMA 274 1995 639-644
4. Fridkin S.K. Steward C.D. Edwards J.R. et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2 Clin Infect Dis 29 1999 245-252
5. Voss A. Milatovic D. Wallrauch-Schwarz C. Rosdahl V.T. Braveny I. Methicillin-resistant Staphylococcus aureus in Europe Eur J Clin Microbiol Infect Dis 13 1994 50-55
6. Dukta-Malen S. Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR J Clin Microbiol 33 1995 24-27 published erratum appears in J Clin Microbiol 1995; 33: 1434
7. Andrews J.M. BSAC standardized disc susceptibility testing method J Antimicrob Chemother 48 Suppl. SI 2001 43-57
8. Henwood C.J. Livermore D.M. Johnson A.P. et al. Susceptibility of Gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid J Antimicrob Chemother 46 2000 931-940
9. Reacher M.H. Shah A. Livermore D.M. et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis BMJ 320 2000 213-216
10. Woodford N. Livermore D.M. Can we beat MRSA, now we know its genome sequence? Lancet Infect Dis 1 2001 9-10
11. Johnson A.P. Aucken H.M. Cavendish S. et al. Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS) J Antimicrob Chemother 48 2001 143-144
12. Fitch L. Johnson A.P. Reduced susceptibility to teicoplanin in a methicillin-resistant strain of Staphylococcus aureus J Antimicrob Chemother 41 1998 578
13. Hassan I.A. Chadwick P.R. Johnson A.P. Clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to teicoplanin in Northwest England J Antimicrob Chemother 48 2001 454-455
14. Elsaghier A.A.F. Aucken H.M. Hamilton-Miller J.M. Shaw S. Kibbler C.C. Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection J Antimicrob Chemother 49 2002 423-424
15. Aucken H.M. Ganner M. Murchan S. Cookson B.D. Johnson A.P. A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics J Antimicrob Chemother 50 2002 171-175
16. MacKenzie F.M. Greig P. Morrison D. Edwards G. Gould I.M. Identification and characterization of teicoplanin-intermediate Staphylococcus aureus blood culture isolates in NE Scotland J Antimicrob Chemother 50 2002 689-697
17. Zurenko GE, Todd WM, Hafkin B et al. Development of linezolid-resistant Enterococcus faecium in two compassionate use program patients treated with linezolid. In Program and Abstracts of the 39th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, USA, 1999, Abstract 848.
18. Gonzales R.D. Schreckenberger P.C. Graham M.B. Kelkar S. DenBesten K. Quinn J.P. Infections due to vanomycin-resistant Enterococcus faecium resistant to linezolid Lancet 357 2001 1179
19. Tsiodras S. Gold H.S. Sakoulas G. et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus Lancet 358 2001 207-208
20. Auckland C. Teare L. Cooke F. et al. Linezolid-resistant enterococci: report of the first isolates in the United Kingdom J Antimicrob Chemother 50 2002 743-746
21. Johnson A.P. Tysall L. Stockdale M.W. et al. Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit Eur J Clin Microbiol Infect Dis 10 2002 751-754
22. Herrero I.A. Issa N.C. Patel R. Nosocomial spread of linezolid-resistant vancomycin-resistant Enterococcus faecium N Engl J Med 346 2002 867-869